Latest

neuropharmacology

Brain Cancer Featured Genetics Neuroscience

·September 4, 2023·5 min read

Two Key Genes Revealed in Chemotherapy Resistance

Researchers identified two genes - NEK2 and INHBA - responsible for causing chemotherapy resistance in head and neck cancer patients. Remarkably, when these genes are silenced, previously resistant cancer cells begin responding to chemotherapy.

Featured Neurology Neuroscience

·September 3, 2023·5 min read

Multiple Sclerosis Drug Shows Promise as New Alzheimer’s Therapy

A groundbreaking revealed that ponesimod, a drug originally used to treat multiple sclerosis, shows potential in treating Alzheimer’s disease. Researchers found that the medication reduces neuroinflammation, a critical factor in Alzheimer’s progression.

Featured Neuroscience

·August 31, 2023·5 min read

Brain’s Weight Switch Found: Eat What You Want, Lose Weight With New Treatment

A revolutionary discovery reveals that astrocytes, star-shaped cells in the brain, play a key role in regulating fat metabolism and obesity. These cells act on a cluster of neurons, known as the GABRA5 cluster, effectively acting as a "switch" for weight regulation.

Featured Neuroscience

·August 30, 2023·7 min read

Vaccines on Horizon to Prevent Fentanyl and Heroin Overdoses

Researchers are nearing human trials for vaccines aimed at preventing fentanyl and heroin overdoses. The vaccines could offer a lifeline to those struggling with opioid addiction or at risk of accidental overdose.

Featured Neurology Neuroscience

·August 11, 2023·4 min read

Long-term Acid Reflux Drugs Linked to Higher Dementia Risk?

Long-term use (over 4.4 years) of proton pump inhibitors, prescribed for acid reflux, may be associated with an increased risk of dementia. However, this research does not establish a direct causation but reveals an association.

Featured Neuroscience

·August 7, 2023·6 min read

Innovative Antibody Counteracts Deadly Opioid Overdoses

Researchers developed an antibody with significant potential to reverse the lethal effects of a carfentanil overdose, according to preclinical tests. Carfentanil, a potent variant of the synthetic opioid fentanyl, is often mixed with illicit drugs, leading to a high number of overdoses.

Featured Neuroscience Psychology

·July 26, 2023·7 min read

Glutamate Receptor Activation: A Potential Cure for Opioid Addiction?

Scientists discovered a potential new weapon in the battle against opioid use disorder (OUD), a condition that affects over two million people in the U.S. alone. The drug, ADX106772, acts on metabotropic glutamate 2 receptors in the brain, leading to a reduction in oxycodone intake and drug-seeking behavior in an animal model.

Featured Neurology Neuroscience Pain

·July 24, 2023·5 min read

Easing Pain, Safely: Antidepressant’s Promise for Neuropathic Pain Relief

Neuropathic pain, impacting an estimated 10% of the global population, could be tackled more safely and effectively with the atypical antidepressant tianeptine. Researchers found that tianeptine offers rapid, long-lasting relief from pain with a lower risk of addiction.

Featured Neurology Neuroscience

·July 20, 2023·3 min read

Is A Fitness Supplement A Potential Ally Against Alzheimer’s?

Researchers have found that the muscle-building supplement HMB (beta-hydroxy beta-methylbutyrate), commonly used by bodybuilders, could help protect memory and slow the progression of Alzheimer's disease. Mouse studies showed HMB reduced Alzheimer's plaques and enhanced factors for neuronal growth, safeguarding learning and memory.

Featured Neurology Neuroscience

·July 17, 2023·5 min read

Donanemab: A Promising Step Forward in Early-Stage Alzheimer’s Treatment

A third new Alzheimer's drug, donanemab, is set for FDA approval, marking a significant step in slowing the progression of the disease. However, these treatments, which work best in the disease's early stages, may not suffice for patients with advanced Alzheimer's.

Featured Neurology Neuroscience

·July 17, 2023·4 min read

Anti-Inflammatory Drugs: A Pathway to Alzheimer’s Treatment

A new study sheds light on how certain anti-inflammatory drugs may prove to be effective treatments for Alzheimer's disease (AD). The team zeroed in on a protein known as p38.

Featured Neurology Neuroscience

·July 1, 2023·6 min read

Lecanemab Alzheimer’s Treatment Set for FDA Approval

Doctors are preparing to administer lecanemab, a promising new Alzheimer's disease treatment nearing FDA approval. This therapy, marketed as Leqembi, slows cognitive decline by extracting amyloid proteins from the brain, thus decreasing tau protein accumulation.

1 … 18 19 20 21 22 … 85

neuropharmacology

Two Key Genes Revealed in Chemotherapy Resistance

Multiple Sclerosis Drug Shows Promise as New Alzheimer’s Therapy

Brain’s Weight Switch Found: Eat What You Want, Lose Weight With New Treatment

Vaccines on Horizon to Prevent Fentanyl and Heroin Overdoses

Long-term Acid Reflux Drugs Linked to Higher Dementia Risk?

Innovative Antibody Counteracts Deadly Opioid Overdoses

Glutamate Receptor Activation: A Potential Cure for Opioid Addiction?

Easing Pain, Safely: Antidepressant’s Promise for Neuropathic Pain Relief

Is A Fitness Supplement A Potential Ally Against Alzheimer’s?

Donanemab: A Promising Step Forward in Early-Stage Alzheimer’s Treatment

Anti-Inflammatory Drugs: A Pathway to Alzheimer’s Treatment

Lecanemab Alzheimer’s Treatment Set for FDA Approval

How Your Brain Saves Nostalgia From Scandals

Dietary Lecithin Linked to Lower Cognitive Impairment

How to Map Brain Circuits Without Touching a Single Neuron

Overlooked Blood Cell May Tracks Parkinson’s Brain Changes

Subscribe